Year: 2019
Type: article
Language: English
Subfield: Emergency Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Veterans Affairs, American Heart Association, Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, Bayer, GlaxoSmithKline, Sanofi, Brigham and Women's Hospital, Biogen, Alnylam Pharmaceuticals, Health Services Research and Development, Harvard Catalyst, Cleveland Clinic, Boston VA Research Institute, Regeneron Pharmaceuticals, Amarin Corporation, Kowa Company, Luitpold Pharmaceuticals, Singulex, Regado Biosciences, Belvoir Media Group, European Commission, Daiichi-Sankyo, Eisai, Novo Nordisk, Vifor Pharma, National Institutes of Health, St. Jude Medical, Relypsa, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences, Duke Clinical Research Institute
Awards: G1002399224, G1582254496, G1717162763, G2032961523, G2086240959, Training Grant in Cardiovascular Research, G2330100590, G2620977245, G2626388858, G3029506724, G3289273305, G3395997892, Training in Cardiovascular Research, G4463822314, G466017000, G4880724714, G5088351700, G5205953702, G5217400600, G5670741473, G6355960561, G7199114025, G7365228695, G7685338055, G8753701226, G8909023964, G9000037139, G9000045113, G9000065669, Research Training in CVD Epidemiology and Prevention, G9000082636, G9000163137, G9000183014
OpenAlex ID: W2925167792